600267 海正药业
已收盘 02-17 15:00:00
资讯
新帖
简况
海正药业:公司会尽力做好每一款产品的销售工作
互动易 · 02-14 18:00
海正药业:公司会尽力做好每一款产品的销售工作
海正药业:公司对环境保护一直非常重视,对于生产过程中产生的废气都有针对性的处理设施,废气排放口安装了在线监测装置
互动易 · 02-14 17:51
海正药业:公司对环境保护一直非常重视,对于生产过程中产生的废气都有针对性的处理设施,废气排放口安装了在线监测装置
海正药业:我们会认真研究大家关心的问题和建议
互动易 · 02-14 17:51
海正药业:我们会认真研究大家关心的问题和建议
海正药业(600267)2月12日主力资金净卖出1516.60万元
证券之星 · 02-13
海正药业(600267)2月12日主力资金净卖出1516.60万元
医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗
研报虎 · 02-11
医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗
医药行业周报:诺华三抗新药PIT565在华再获批临床 用于SLE
太平洋证券股份... · 02-11
医药行业周报:诺华三抗新药PIT565在华再获批临床 用于SLE
部分集采药陷质量争议,医保药监:将持续加强药品质量监管,支持更大范围考察药品疗效
时代财经 · 02-10
部分集采药陷质量争议,医保药监:将持续加强药品质量监管,支持更大范围考察药品疗效
国家医保局:把较高质量风险产品排除在集采之外
智通财经 · 02-10
国家医保局:把较高质量风险产品排除在集采之外
“血压不降、麻药不睡、泻药不泻”,官方最新回应!
南方都市报 · 02-09
“血压不降、麻药不睡、泻药不泻”,官方最新回应!
十年首次!一年净赚6亿,海正药业到了重估时刻
中金在线 · 02-09
十年首次!一年净赚6亿,海正药业到了重估时刻
海正药业:海复康是高效的RNA聚合酶抑制剂抗病毒药物
互动易 · 02-07
海正药业:海复康是高效的RNA聚合酶抑制剂抗病毒药物
海正药业:公司目前持有子公司海正动保的股份比例为66.34%
互动易 · 02-07
海正药业:公司目前持有子公司海正动保的股份比例为66.34%
海正药业:希望通过与AI制药公司合作助力新药研发突破技术壁垒
互动易 · 02-07
海正药业:希望通过与AI制药公司合作助力新药研发突破技术壁垒
海正药业:公司正在全力推进海复康的推广和销售工作
互动易 · 02-07
海正药业:公司正在全力推进海复康的推广和销售工作
海正药业:公司已经尝试开发处方罐头同时研究布局宠物处方粮等领域
互动易 · 02-07
海正药业:公司已经尝试开发处方罐头同时研究布局宠物处方粮等领域
海正药业:药品从研发生产到销售的每一个环节都受到严格监管
互动易 · 02-07
海正药业:药品从研发生产到销售的每一个环节都受到严格监管
海正药业(600267)2月6日主力资金净买入1020.00万元
证券之星 · 02-07
海正药业(600267)2月6日主力资金净买入1020.00万元
最新连涨个股来了!海正药业11连涨
东方财富研究中心 · 01-27
最新连涨个股来了!海正药业11连涨
一周复盘 | 海正药业本周累计上涨4.03%,化学制药板块下跌0.29%
金融界 · 01-26
一周复盘 | 海正药业本周累计上涨4.03%,化学制药板块下跌0.29%
最新连涨个股来了!海正药业10连涨
东方财富研究中心 · 01-24
最新连涨个股来了!海正药业10连涨
暂无数据
公司概况
公司名称:
浙江海正药业股份有限公司
所属行业:
医药制造业
上市日期:
2000-07-25
主营业务:
浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,公司的主要产品及服务是医药制剂-自营业务、医药制剂-渠道及创新业务等。公司专注于化学药,生物药,动物药,中药及商业流通等多产业发展,加快布局大健康产业和健康美学等新兴市场,多次入选中国制造业企业500强,中国医药工业百强企业榜单,先后荣获国家技术创新示范企业,全国五一劳动奖状,浙江省政府质量奖等荣誉称号。此外,报告期内公司还获得“2023年度中国化药企业TOP100”,“浙江省知产保护警企合作基地”,“浙江出口名牌”等荣誉。
发行价格:
11.83
{"stockData":{"symbol":"600267","market":"SH","secType":"STK","nameCN":"海正药业","latestPrice":8.77,"timestamp":1739775601000,"preClose":8.85,"halted":0,"volume":15455475,"delay":0,"changeRate":-0.009,"floatShares":1198000000,"shares":1199000000,"eps":-0.0169,"marketStatus":"已收盘","change":-0.08,"latestTime":"02-17 15:00:00","open":8.93,"high":8.96,"low":8.72,"amount":137000000,"amplitude":0.0271,"askPrice":8.78,"askSize":66,"bidPrice":8.77,"bidSize":415,"shortable":0,"etf":0,"ttmEps":-0.0169,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1739842200000},"marketStatusCode":5,"adr":0,"adjPreClose":8.85,"symbolType":"stock","openAndCloseTimeList":[[1739755800000,1739763000000],[1739768400000,1739775600000]],"highLimit":9.74,"lowLimit":7.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1198848196,"isCdr":false,"pbRate":1.27,"roa":"--","roe":"6.4%","epsLYR":-0.08,"committee":0.34451,"marketValue":10514000000,"turnoverRate":0.0129,"status":1,"floatMarketCap":10508000000},"requestUrl":"/m/hq/s/600267/tweets","defaultTab":"tweets","newsList":[{"id":"2511687916","title":"海正药业:公司会尽力做好每一款产品的销售工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511687916","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511687916?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:00","pubTimestamp":1739527202,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 法维拉韦是我国首款国产RNA聚合酶抑制剂、 通过抑制病毒RNA复制和诱发病毒致命性突变的双重机制、直接抑制病毒复制以获取更强的病毒杀伤。作为广谱抗病毒药物法维拉韦、对包括甲型、乙型流感和新冠病毒在内的多种RNA病毒有效,其耐药风险低于奥司他韦和玛巴洛沙韦。由于蛋白结合率更低药物相互作用更少,对包括老年人、合并基础疾病、重症等特殊人群而言临床安全性更佳。但身边的药店买不到,老百姓不知道,海正药业要宣传宣传宣传公司回答表示,尊敬的投资者您好!公司会尽力做好每一款产品的销售工作,也正在全力推进海复康的推广和销售工作,感谢您对公司的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214180941abcec316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214180941abcec316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600267","BK0188","BK0060","BK0239"],"gpt_icon":0},{"id":"2511650206","title":"海正药业:公司对环境保护一直非常重视,对于生产过程中产生的废气都有针对性的处理设施,废气排放口安装了在线监测装置","url":"https://stock-news.laohu8.com/highlight/detail?id=2511650206","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511650206?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:51","pubTimestamp":1739526660,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 公司领导您好!我是一名城市居民,对空气污染问题很关心。不知贵公司在生产过程中,是否有针对性地采取措施来降低对空气环境的影响?期待与贵公司共同努力,守护城市的蓝天公司回答表示,尊敬的投资者您好!公司对环境保护一直非常重视,对于生产过程中产生的废气都有针对性的处理设施,废气排放口安装了在线监测装置。感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214175716a245ba98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214175716a245ba98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600267","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2511203650","title":"海正药业:我们会认真研究大家关心的问题和建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2511203650","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511203650?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:51","pubTimestamp":1739526660,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 1月24日,北京佑安医院感染综合科主任医师李侗曾受邀做客人民日报健康客户端主办的《人民名医》节目,就《流行性感冒诊疗方案(2025年版)》进行了解读,李侗曾指出,对于已经对奥司他韦和玛巴洛沙韦产生耐药性的流感毒株,法维拉韦仍然能够有效发挥作用。除了对甲流和乙流有效外,还对丙型流感、诺如病毒、埃博拉病毒、黄热病病毒以及西布尼亚病毒等多种RNA病毒具有抑制作用。海正研发并开展临床试验,法维拉韦增加诺如病毒适应症?公司回答表示,尊敬的投资者您好!我们会认真研究大家关心的问题和建议。感谢您对公司的关注,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214175648abcebf24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214175648abcebf24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0060","BK0188","600267"],"gpt_icon":0},{"id":"2511558251","title":"海正药业(600267)2月12日主力资金净卖出1516.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511558251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511558251?lang=zh_cn&edition=full","pubTime":"2025-02-13 08:33","pubTimestamp":1739406790,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月12日收盘,海正药业报收于8.74元,下跌0.79%,换手率0.91%,成交量10.91万手,成交额9552.24万元。近5日资金流向一览见下表:海正药业融资融券信息显示,融资方面,当日融资买入1032.77万元,融资偿还990.76万元,融资净买入42.01万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021300008726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","BK0060","600267"],"gpt_icon":0},{"id":"2510827757","title":"医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2510827757","media":"研报虎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510827757?lang=zh_cn&edition=full","pubTime":"2025-02-11 13:59","pubTimestamp":1739253565,"startTime":"0","endTime":"0","summary":"2025年第四十三届摩根大通医疗健康年会盛大召开。我们从本次会议的热点一窥行业创新升级的重点方向,关注抗体偶联药物、双特异性抗体、细胞与基因治疗等生物创新药领域的最新进展。2025JPM大会展示的ADC药物多达数十款,基本为第三代产品,面向肺癌、乳腺癌、肺癌等高发实体瘤,涌现出一大批创新前沿的生物技术公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688321","688553","688356","600521","BK0239","600380","603669","688266","688117","BK0183","603707","600062","603207","688578","605507","688197","603168","BK0012","600513","600420","BK0060","688373","BK0188","688690","600488","603351","688566","BK0096","BK0187","600196","688428","BK0028","603229","688602","688189","600774","600216","688506","603538","605177","688176","600664","688235","603367","603811","600624","688658","688799","601089","603520","600267","603676","688247","688513","600200","600613","688505","BK0175","BK0196","159760","605116","688221","159992","600079","600276","688302"],"gpt_icon":0},{"id":"2510277958","title":"医药行业周报:诺华三抗新药PIT565在华再获批临床 用于SLE","url":"https://stock-news.laohu8.com/highlight/detail?id=2510277958","media":"太平洋证券股份...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510277958?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:00","pubTimestamp":1739203200,"startTime":"0","endTime":"0","summary":"行业要闻:近日,中国国家药监局药品审评中心官网公示,诺华申报的1 类新药PIT565 获得一项新的临床试验默示许可,拟开发治疗系统性红斑狼疮。PIT565 是一款抗CD3/CD19/CD2 的三特异性抗体,可以靶向恶性B 细胞上的CD19,同时可与T 细胞上的CD3和CD2结合。与CD3 双特异性相比,通过PIT565共刺激CD2 可能会克服T 细胞衰竭,增加患者反应的深度和持续时间,该药此前在华获批针对B 细胞恶性肿瘤的IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211120756961eb981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","603976","688221","688236","BK0028","601089","688468","688139","603811","688235","688317","688428","688076","688758","688426","688247","605116","688382","600587","600196","600851","688016","688151","603309","600613","688399","600079","605177","688302","BK0239","688606","600200","600488","603301","688513","688198","688602","688617","600529","603658","688690","603676","603351","688580","600055","603168","688358","603669","603707","603207","688298","600807","688658","603987","688273","600789","688575","600521","688026","603520","688626","688189","688062","600624","603387","688578","BK0188","603222","603880","688389","603538","688799","688050","688212","688506","600062","688505","688321","688117","600420","688373","605369","688075","688091","688192","688067","688193","688217","688613","603229","688176","688108","603205","688271","688029","688581","600513","688576","688166","600216","600645","688266","600812","603367","600380","600267","688013","688085","688197","688607","688553","688566","600276","688677","688338","605507","600664","688161","688767","600774","BK0060"],"gpt_icon":0},{"id":"2510887125","title":"部分集采药陷质量争议,医保药监:将持续加强药品质量监管,支持更大范围考察药品疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2510887125","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510887125?lang=zh_cn&edition=full","pubTime":"2025-02-10 12:39","pubTimestamp":1739162344,"startTime":"0","endTime":"0","summary":"尤其是药品质量方面,上述相关部门指出,药品质量安全不仅是企业的生命线,也是监管部门的底线。长期以来,药监部门对药品质量、尤其对集采中选药品质量严格监管,坚持“全覆盖”“零容忍”。国家医保部门、药监部门对媒体称。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210123918961d7421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210123918961d7421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603520","600812","688197","688176","600521","603707","688553","688758","BK0188","BK0239","688076","603229","688091","BK0168","600774","600789","600196","BK0046","603351","603669","688166","688221","600624","688189","688566","688321","688356","600613","688373","600267","688247","688302","688505","688513","688658","688062","603168","600513","688428","600200","688192","600664"],"gpt_icon":0},{"id":"2510488390","title":"国家医保局:把较高质量风险产品排除在集采之外","url":"https://stock-news.laohu8.com/highlight/detail?id=2510488390","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510488390?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:43","pubTimestamp":1739155385,"startTime":"0","endTime":"0","summary":"2018年以来的持续实践,既让集采政策和集采药品得到了临床检验,也让我国患者的主流用药实现了从“未过评仿制药”到“过评仿制药”的跨越。在进一步完善集采政策方面,国家医保局表示,将广泛了解药品接受日常监管情况,把存在较高质量风险的产品排除在集采之外。对于预计投标企业数量超过一定规模、竞争比较激烈的品种,提前进行强竞争预警,提示企业慎重决策,科学投标,理性报价。对偏离度高的最低报价予以重点关注,并请企业及时公开回应有关关切。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104444961d5cc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104444961d5cc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","688321","600196","LU2488822045.USD","603811","LU1969619763.USD","605177","603229","600624","600521","603538","688062","600200","600613","LU1328615791.USD","688076","600420","688302","688382","600216","603168","BK0196","BK0012","688356","LU1064130708.USD","688505","688799","688266","600062","600513","688373","688428","LU2328871848.SGD","600276","688553","BK0188","603669","688235","688192","600488","BK0239","688247","600267","600380","603207","BK0183","600664","603367","688602","600789","600851","605507","LU0405327148.USD","688578","BK0028","688197","603707","688690","688176","688166","688091","605116","688566","LU2148510915.USD","688758","688658","688117","601089","600079","603351","688221","603520","688513","600812","603676","600774","BK0060","LU1064131003.USD","LU0405327494.USD","688506"],"gpt_icon":0},{"id":"2510188717","title":"“血压不降、麻药不睡、泻药不泻”,官方最新回应!","url":"https://stock-news.laohu8.com/highlight/detail?id=2510188717","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510188717?lang=zh_cn&edition=full","pubTime":"2025-02-09 16:37","pubTimestamp":1739090269,"startTime":"0","endTime":"0","summary":"据国家医保局今天下午消息:今年1月,有专家认为某些集采药品可能存在“血压不降、麻药不睡、泻药不泻”质量风险。瑞金医院及其他几家医院均反映,未收到临床一线关于“泻药不泻”的相关反馈。总的来看,此次关于“血压不降、麻药不睡、泻药不泻”等说法,多来自他人转述和主观感受。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209164530abc8199a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209164530abc8199a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","603676","603168","688192","600774","600789","603229","BK0239","600664","688566","688428","688197","688513","688658","688091","688221","600267","603351","605177","688321","600613","603707","603207","688176","600521","688690","688166","688247","688062","688302","688553","688076","603520","688373","688356","600812","600513","688505","600488","600624","688189","688758","600200","603669","600196"],"gpt_icon":0},{"id":"2510379019","title":"十年首次!一年净赚6亿,海正药业到了重估时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2510379019","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510379019?lang=zh_cn&edition=full","pubTime":"2025-02-09 15:53","pubTimestamp":1739087584,"startTime":"0","endTime":"0","summary":"数年的变革和刷新,海正药业终于迎来好消息。面临此前数年积弊,海正药业更需直面改革。2020年,海正药业重点推进瀚晖制药的资产重组业务,同时积极推进欧盟整改。2019年,海正药业扭亏为盈,2020年归母净利润同比大增348.25%。自1992年首次通过美国FDA审计起,海正药业积累了30多年在全球70多个国家和地区的中高端原料药市场的资源网络。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209160208961cc697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209160208961cc697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0188","BK0239","BK0028","BK0060"],"gpt_icon":0},{"id":"2509713607","title":"海正药业:海复康是高效的RNA聚合酶抑制剂抗病毒药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2509713607","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509713607?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920964,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 广谱抗病毒利器-法维拉韦纳入《流行性感冒诊疗方案(2025年版)》后,通过DeepSeek预测2025年海复康法维拉韦销售额:保守估计年销售额或突破5亿元,请问海正管理层2025年海复康法维拉韦销售目标是多少?公司回答表示,尊敬的投资者您好!海复康是高效的RNA聚合酶抑制剂抗病毒药物,其作为广谱抗流感药物已经列入医保药品,公司会尽力做好每一款产品的销售工作,我们希望海复康能更好的服务广大患者,公司正在积极推广中,感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174537a23cdb35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174537a23cdb35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","BK0060","600267","BK0188"],"gpt_icon":0},{"id":"2509713989","title":"海正药业:公司目前持有子公司海正动保的股份比例为66.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509713989","media":"互动易","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509713989?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920962,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 你好董秘,海正药业持有海正动保公司的股份是多少?谢。公司回答表示,尊敬的投资者您好!公司目前持有子公司海正动保的股份比例为66.34%。谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174539abc5e227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174539abc5e227&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0188","600267","BK0060"],"gpt_icon":0},{"id":"2509713980","title":"海正药业:希望通过与AI制药公司合作助力新药研发突破技术壁垒","url":"https://stock-news.laohu8.com/highlight/detail?id=2509713980","media":"互动易","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509713980?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920962,"startTime":"0","endTime":"0","summary":"请问贵公司怎么看待未来AI制药的,贵公司在AI制药方向有技术和业务布局吗?AI制药以医药大数据为基础,将人工智能技术应用到制药各环节,提高新药研发效率及质量,降低研发成本。公司高度认可AI技术对未来产业发展的赋能潜力,希望通过与AI制药公司的战略合作,助力新药研发突破技术壁垒,推进人工智能在药物研发阶段的应用落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174529abc5e219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174529abc5e219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0060","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2509983713","title":"海正药业:公司正在全力推进海复康的推广和销售工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2509983713","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509983713?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920961,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 恭祝广谱抗病毒利器-法维拉韦纳入《流行性感冒诊疗方案(2025年版)》,关于海复康营销有几个建议:1、高度重视,作为公司最重要产品来推进2、强化网上营销,让更多的医生在抖音推荐海复康法维拉韦 等其他营销手段 3、强化线下医院药店营销,集中所有人开展营销工作。问题:京东上搜索法维拉韦、海复康弹出流感预防特效药-海复康介绍,但是搜索流感、流感特效药根本不显示海复康的产品介绍,这样起不到宣传效果,能否改。公司回答表示,尊敬的投资者您好!公司正在全力推进海复康的推广和销售工作,非常感谢您对公司的关注及宝贵建议!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174531abc5e21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174531abc5e21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","BK0060","600267","BK0188"],"gpt_icon":0},{"id":"2509713984","title":"海正药业:公司已经尝试开发处方罐头同时研究布局宠物处方粮等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2509713984","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509713984?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920961,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 尊敬的领导,您好。动物药业务致力于为农场动物与伴侣动物提供动物健康解决方案,所在的行业市场空间巨大,具有广阔的成长空间。目前化药、疫苗协同发展,已成为国内动物药领域的领先品牌,是公司重点扶持打造的具有高潜力的业务板块。在宠物食品领域,公司已经尝试开发处方罐头,同时,利用公司推进合成生物学的契机在研究布局大动物饲料原料及宠物处方粮等领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174539a23cdb39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174539a23cdb39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0239","BK0028","BK0188","BK0060"],"gpt_icon":0},{"id":"2509713936","title":"海正药业:药品从研发生产到销售的每一个环节都受到严格监管","url":"https://stock-news.laohu8.com/highlight/detail?id=2509713936","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509713936?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:36","pubTimestamp":1738920960,"startTime":"0","endTime":"0","summary":"有投资者向海正药业提问, 针对贵公司广谱抗病毒利器-海复康,广大股民有个建议:把包装改成20片/盒,价格下降一半,相信一定大卖。希望公司尽快研究!非常感谢您对公司的关注及建议,我们会认真研究广大股民关心的问题。依据《药品管理法》及相关法律法规,药品从研发、生产到销售的每一个环节,都受到严格监管,我们会依据相关法律法规,并结合药品说明书用法用量和临床需求等酌情办理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174533a23cdb30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207174533a23cdb30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600267","BK0239","BK0060","BK0188"],"gpt_icon":0},{"id":"2509734673","title":"海正药业(600267)2月6日主力资金净买入1020.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509734673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509734673?lang=zh_cn&edition=full","pubTime":"2025-02-07 08:42","pubTimestamp":1738888952,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月6日收盘,海正药业报收于8.75元,下跌0.57%,换手率1.65%,成交量19.77万手,成交额1.72亿元。近5日资金流向一览见下表:海正药业融资融券信息显示,融资方面,当日融资买入3564.29万元,融资偿还1991.02万元,融资净买入1573.27万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020700005809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","600267","BK0060"],"gpt_icon":0},{"id":"2506327160","title":"最新连涨个股来了!海正药业11连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2506327160","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506327160?lang=zh_cn&edition=full","pubTime":"2025-01-27 18:19","pubTimestamp":1737973140,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示,截至1月27日收盘,有644股连涨3天(含,以下同)以上,其中28股连涨5天以上,最长的海正药业连涨11天。从股价涨幅来看,8连涨的冀东装备,累计上涨81.08%。*ST信通紧随其后,10天累计上涨62.57%。普联软件4连涨,累计涨幅59.45%。新炬网络、彩讯股份、每日互动等连涨股也涨幅靠前。机械设备分布居首从行业分布来看,最新连涨的644股,分布于医药生物最多,为68股。基础化工紧随其后,为62股。计算机为49股。(文章来源:东方财富研究中心)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127182317961209b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127182317961209b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0239","BK0188","BK0028","600267"],"gpt_icon":0},{"id":"2506846173","title":"一周复盘 | 海正药业本周累计上涨4.03%,化学制药板块下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506846173","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506846173?lang=zh_cn&edition=full","pubTime":"2025-01-26 10:55","pubTimestamp":1737860150,"startTime":"0","endTime":"0","summary":"海正药业本周累计上涨4.03%,周总成交额5.66亿元,截至本周收盘,海正药业股价为8.52元。从股价涨幅来看,6连涨的兴业股份,累计上涨77.07%。冀东装备紧随其后,7天累计上涨64.58%。海正药业预计2024年扭亏为盈1月22日晚间,海正药业发布2024年业绩预告,报告期内,预计实现归属于上市公司股东的净利润5.7亿元到6.3亿元,与上年同期相比,将实现扭亏为盈。1月23日,海正药业开盘后一度涨超4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/26105547829390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","01477","BK0028","BK0239","BK1574","BK0060","BK1191","600267"],"gpt_icon":0},{"id":"2505855355","title":"最新连涨个股来了!海正药业10连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2505855355","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505855355?lang=zh_cn&edition=full","pubTime":"2025-01-24 18:52","pubTimestamp":1737715936,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示,截至1月24日收盘,有201股连涨3天(含,以下同)以上,其中65股连涨5天以上,最长的海正药业连涨10天。从股价涨幅来看,6连涨的兴业股份,累计上涨77.07%。冀东装备紧随其后,7天累计上涨64.58%。华联股份5连涨,累计涨幅60.94%。*ST信通、晋拓股份、长盈通等连涨股也涨幅靠前。机械设备分布居首从行业分布来看,最新连涨的201股,分布于机械设备最多,为31股。计算机紧随其后,为28股。电子为17股。通信、医药生物、电力设备也分布靠前。文章来源:东方财富研究中心","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124190002abb71309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124190002abb71309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0188","600267","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2000-07-25","address":"浙江省台州市椒江区外沙路46号","stockEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":0.1104},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.1508},{"period":"1year","weight":0.1317},{"period":"ytd","weight":0.0663}],"companyName":"浙江海正药业股份有限公司","boardCode":"AI0027","perCapita":"21275股","boardName":"医药制造业","registeredCapital":"119884万元","compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0371},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.1678},{"period":"ytd","weight":-0.0015}],"survey":" 浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,公司的主要产品及服务是医药制剂-自营业务、医药制剂-渠道及创新业务等。公司专注于化学药,生物药,动物药,中药及商业流通等多产业发展,加快布局大健康产业和健康美学等新兴市场,多次入选中国制造业企业500强,中国医药工业百强企业榜单,先后荣获国家技术创新示范企业,全国五一劳动奖状,浙江省政府质量奖等荣誉称号。此外,报告期内公司还获得“2023年度中国化药企业TOP100”,“浙江省知产保护警企合作基地”,“浙江出口名牌”等荣誉。","serverTime":1739776424710,"listedPrice":11.83,"stockholders":"56319人(较上一季度减少3.58%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海正药业,600267,海正药业股票,海正药业股票老虎,海正药业股票老虎国际,海正药业行情,海正药业股票行情,海正药业股价,海正药业股市,海正药业股票价格,海正药业股票交易,海正药业股票购买,海正药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}